Sylke
Sylke is a startup headquartered in La Jolla, United States, founded in 2023. It has raised at least $10.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Sylke has raised at least $10.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Sylke sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in La Jolla
- A28 Therapeutics
- AeroRx Therapeutics
- Arialys Therapeutics
- DEPTH Health
- Enlaza Therapeutics
- Paulex Bio
- RightDevice
- Valora Therapeutics
Related
- Innovation profile of La Jolla
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Sylke do?
Sylke is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Sylke raised?
At least $10.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Sylke based?
Sylke is headquartered in La Jolla, United States.
When was Sylke founded?
Sylke was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.